NCT00207402: Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin |
|
|
| Completed | 4 | 34 | US | rosiglitazone, Infergen (interferon alfacon-1), Avandia (rosiglitazone), Ribavirin | Brooke Army Medical Center, InterMune | Hepatitis C | 01/10 | 07/10 | | |
NCT01406704: Effects of Rosiglitazone and Alpha-lipoic Acid on the Patients With Pathologically Proved NASH |
|
|
| Terminated | 4 | 26 | RoW | Rosiglitazone, Avandia, alpha-lipoic acid, Thioctic acid, Rosiglitazone/alpha-lipoic acid, Avandia/Thioctic acid | Seoul St. Mary's Hospital, GlaxoSmithKline | NASH (Non-alcoholic Steato-hepatitis) | 12/10 | 12/13 | | |
